Weight Fluctuation After Breast Cancer Treatment
Launched by THE ROYAL BOURNEMOUTH HOSPITAL · Oct 7, 2009
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Females 18 years of age or older.
- • Diagnosed with breast cancer between 1/1/2003 and 31/12/2007.
- • Able to understand and willing to sign informed consent.
- Exclusion Criteria:
- • Known diagnosis of previous breast/other cancer (other than completely resected non-melanoma skin cancer or successfully treated in situ cancer of the cervix.
- • Known diagnosis of inflammatory bowel disease or malabsorption syndrome.
- • Known diagnosis of endocrine problems associated with the development of obesity (cushings syndrome, hypo/hyperthyroid, thyroiditis)
- • Treatment for psychiatric disorders.
About The Royal Bournemouth Hospital
The Royal Bournemouth Hospital is a leading healthcare institution dedicated to providing high-quality medical care and advancing clinical research. As a prominent clinical trial sponsor, the hospital is committed to enhancing patient outcomes through innovative studies and evidence-based practices. With a multidisciplinary team of experienced healthcare professionals, the Royal Bournemouth Hospital fosters a collaborative environment that prioritizes patient safety and ethical standards. By engaging in cutting-edge research across various medical fields, the hospital aims to contribute significantly to the development of new treatments and healthcare solutions, ultimately improving the quality of life for patients in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Tamas Hickish
Principal Investigator
Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials